Ann Arbor, MI · Founded 2014 · Privately Held (backing)
Developer of high-brightness fluorophores designed to improve the reagents that run through flow cytometers. StabiLux Biosciences is based in Ann Arbor, MI and was founded in 2014. It has raised $1.9 million across 1 recorded round; the latest was a $554,381 seed round in Apr 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$1.9M
Last round
Seed Round
Apr 2024
Cap table — not yet on record
StabiLux Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of StabiLux Biosciences with a free account
·The complete investor list: 12 names
·Watch StabiLux Biosciences: the Monday email on marks, rounds and moves
Where does StabiLux Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across StabiLux Biosciences's 1 recorded funding rounds.